Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Activated PI3K-delta Syndrome”

8 trials

Showing 8 of 8 results

Not applicableLooking for participantsNCT06694363
What this trial is testing

New Biomarker-based Strategy to Screen and Monitor for Activated Phosphoinositide 3-kinase δ Syndrome

Who this might be right for
Activated PI3K Delta Syndrome
Assistance Publique - Hôpitaux de Paris 14
Large-scale testing (Phase 3)UnknownNCT06249997
What this trial is testing

An Open-Label Study to Assess the Safety & Efficacy of Leniolisib in Japanese Patients With APDS

Who this might be right for
APDS Gene Mutation
Pharming Technologies B.V. 3
Large-scale testing (Phase 3)Ended earlyNCT02859727
What this trial is testing

Extension to the Study of Efficacy of CDZ173 in Patients With APDS/PASLI

Who this might be right for
Activated PI3Kdelta Syndrome (APDS); PASLI Disease
Pharming Technologies B.V. 37
Testing effectiveness (Phase 2)Study completedNCT03383380
What this trial is testing

Rapamycin Treatment for Activated Phosphoinositide 3-Kinase δ Syndrome

Who this might be right for
Activated PI3K-delta SyndromeImmunodeficiency Primary
Children's Hospital of Fudan University 30
Large-scale testing (Phase 3)Study completedNCT02435173
What this trial is testing

Study of Efficacy of CDZ173 in Patients With APDS/PASLI

Who this might be right for
Common Variable Immunodeficiency (CVID), APDS / PASLI
Novartis Pharmaceuticals 37
Testing effectiveness (Phase 2)Study completedNCT02593539
What this trial is testing

Safety, Pharmacokinetic (PK) and Pharmacodynamic (PD) Study of Repeat Doses of Inhaled Nemiralisib in Patients With APDS/PASLI

Who this might be right for
Activated PI3K-delta Syndrome
GlaxoSmithKline 5
Large-scale testing (Phase 3)Active Not RecruitingNCT05438407
What this trial is testing

Pediatric Patients Aged 4 to 11 Years With APDS

Who this might be right for
APDS
Pharming Technologies B.V. 15
Large-scale testing (Phase 3)Active Not RecruitingNCT05693129
What this trial is testing

Pediatric Patients Aged 1 to 6 Years With APDS

Who this might be right for
APDS
Pharming Technologies B.V. 16

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation